Annual Financials for HealthEquity Inc.
Fiscal year is February-January. All values USD millions. |
2019 | 2020 | 2021 | 2022 | 2023 |
5-year trend |
Sales/Revenue
|
287.24M | 531.99M | 733.57M | 756.56M | 861.75M | |
Sales Growth |
- | 85.21% | 37.89% | 3.13% | 13.90% | |
Cost of Goods Sold (COGS) incl. D&A |
111.98M | 240.79M | 394.3M | 415.64M | 466.24M | |
COGS excluding D&A |
93.79M | 185.44M | 278.4M | 278.45M | 305.04M | |
Depreciation & Amortization Expense |
18.19M | 55.35M | 115.9M | 137.19M | 161.2M | |
Depreciation |
3.5M | 8.9M | 16M | 14.7M | 66.62M | |
Amortization of Intangibles |
14.69M | 46.45M | 99.9M | 122.49M | 94.59M | |
COGS Growth |
- | 115.03% | 63.75% | 5.41% | 12.17% | |
Gross Income |
175.26M | 291.21M | 339.27M | 340.92M | 395.51M | |
Gross Income Growth |
- | 66.15% | 16.51% | 0.48% | 16.01% | |
Gross Profit Margin |
- | - | - | - | 45.90% | NA |
|
2019 | 2020 | 2021 | 2022 | 2023 |
5-year trend |
SG&A Expense |
97.59M | 182.09M | 259.27M | 300.35M | 357.85M | |
Research & Development |
35.06M | 77.58M | 124.81M | 157.36M | 193.38M | |
Other SG&A |
62.54M | 104.51M | 134.46M | 142.98M | - | |
SGA Growth |
- | 86.58% | 42.39% | 15.85% | 19.15% | |
Other Operating Expense |
- | - | - | - | - | |
Unusual Expense |
2.1M | 72.92M | 47.11M | 77.54M | 28.6M | |
EBIT after Unusual Expense |
75.57M | 36.2M | 32.9M | (36.97M) | 9.06M | |
Non Operating Income/Expense |
248,000 | 25.83M | 5.08M | 1.25M | 1.27M | |
Non-Operating Interest Income |
- | 5.91M | 1.05M | 1.5M | - | |
Equity in Affiliates (Pretax) |
- | - | - | - | - | |
Interest Expense |
- | 24.77M | 34.88M | 32.52M | 48.42M | |
Interest Expense Growth |
- | - | 40.81% | -6.76% | 48.89% | |
Gross Interest Expense |
- | 24.77M | 34.88M | 32.52M | 48.42M | |
Interest Capitalized |
- | - | - | - | - | |
Pretax Income |
75.82M | 43.16M | 4.14M | (66.74M) | (38.1M) | |
Pretax Income Growth |
- | -43.08% | -90.41% | -1,712.10% | 42.92% | |
Pretax Margin |
- | - | - | - | -4.42% | NA |
Income Tax |
1.92M | 3.49M | (4.69M) | (22.45M) | (11.95M) | |
Income Tax - Current Domestic |
1.51M | (174,000) | 439,000 | 867,000 | - | |
Income Tax - Current Foreign |
- | - | - | - | - | |
Income Tax - Deferred Domestic |
408,000 | 3.67M | (5.13M) | (23.32M) | - | |
Income Tax - Deferred Foreign |
- | - | - | - | - | |
Income Tax Credits |
- | - | - | - | - | |
Equity in Affiliates |
- | - | - | - | - | |
Other After Tax Income (Expense) |
- | - | - | - | - | |
Consolidated Net Income |
73.9M | 39.66M | 8.83M | (44.29M) | (26.14M) | |
Minority Interest Expense |
- | - | - | - | - | |
Net Income |
73.9M | 39.66M | 8.83M | (44.29M) | (26.14M) | |
Net Income Growth |
- | -46.33% | -77.73% | -601.35% | 40.97% | |
Net Margin Growth |
- | - | - | - | -3.03% | NA |
Extraordinaries & Discontinued Operations |
- | - | - | - | - | |
Extra Items & Gain/Loss Sale Of Assets |
- | - | - | - | - | |
Cumulative Effect - Accounting Chg |
- | - | - | - | - | |
Discontinued Operations |
- | - | - | - | - | |
Net Income After Extraordinaries |
73.9M | 39.66M | 8.83M | (44.29M) | (26.14M) | |
Preferred Dividends |
- | - | - | - | - | |
Net Income Available to Common |
73.9M | 39.66M | 8.83M | (44.29M) | (26.14M) | |
EPS (Basic) |
1.20 | 0.59 | 0.12 | (0.53) | (0.31) | |
EPS (Basic) Growth |
- | -50.48% | -79.89% | -547.65% | 41.88% | |
Basic Shares Outstanding |
61.84M | 67.03M | 74.24M | 83.13M | 84.44M | |
EPS (Diluted) |
1.17 | 0.58 | 0.12 | (0.53) | (0.31) | |
EPS (Diluted) Growth |
- | -50.32% | -79.86% | -556.47% | 41.88% | |
Diluted Shares Outstanding |
63.37M | 68.45M | 75.68M | 83.13M | 84.44M | |
EBITDA |
95.86M | 164.47M | 195.91M | 177.76M | 198.85M | |
EBITDA Growth |
- | 71.58% | 19.12% | -9.27% | 11.87% | |
EBITDA Margin |
- | - | - | - | 23.08% | NA |